Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Debt / NOTE 5.250%12/0
-
Number of holders
-
11
-
Total 13F principal, excl. options
-
88,139,000
-
Principal change
-
-100,000
-
Total reported value, excl. options
-
$66,588,984
-
Value change
-
-$77,014
-
Number of buys
-
1
-
Number of sells
-
-1
-
Price
-
$0.7417
Significant Holders of LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0 as of Q4 2019
11 filings reported holding 528872AB0 - LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0 as of Q4 2019.
LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0 has 11 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $88,139,000 of principal
.
Largest 10 bondholders include CITADEL ADVISORS LLC ($31,800,000 of principal), Polygon Management Ltd. ($14,500,000 of principal), LAZARD ASSET MANAGEMENT LLC ($12,500,000 of principal), WOLVERINE ASSET MANAGEMENT LLC ($12,250,000 of principal), UBS ASSET MANAGEMENT AMERICAS INC ($10,500,000 of principal), DEUTSCHE BANK AG\ ($4,500,000 of principal), DeepCurrents Investment Group LLC ($1,000,000 of principal), Verition Fund Management LLC ($709,000 of principal), JPMORGAN CHASE & CO ($320,000 of principal), and Federation des caisses Desjardins du Quebec ($30,000 of principal).
This table shows the top 11 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.